25662703

Zhao C

2015

Role of serum miRNAs in the prediction of ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients.

25662759

Haj-Husein I

2016

The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study.

25662806

Huang CC

2015

Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations.

25664123

Huang K

2014

Effect of overweight/obesity on IVF-ET outcomes in chinese patients with polycystic ovary syndrome.

25666342

Lie Fong S

2015

The role of anti-M?llerian hormone in the classification of anovulatory infertility.

25666878

K?se SA

2015

N-acetyl cysteine reduces oxidative toxicity, apoptosis, and calcium entry through TRPV1 channels in the neutrophils of patients with polycystic ovary syndrome.

25667201

Ergenoglu M

2015

Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome.

25668421

Ravn P

2015

New paradigms in PCOS: impaired glucose tolerance and cardiovascular risk. Clinical approach.

25670222

Formuso C

2015

Myo-inositol vs. D-chiro inositol in PCOS treatment.

25670232

Appelman Y

2015

Sex differences in cardiovascular risk factors and disease prevention.

25672133

Komsa-Penkova R

2014

[Reproductive problems in women with PCOS, the impact of PAI-1 carriers of 4G PAI-1 polymorphism and BMI].

25675380

Li M

2015

Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.

25675386

Rosenfield RL

2015

Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood.

25675618

Andreeva P

2014

[Thyroid gland and fertility].

25678248

Ramos RB

2015

Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis.

25681838

Von Hofe J

2015

Ovulation induction.

25681840

Ecklund LC

2015

Endocrine and reproductive effects of polycystic ovarian syndrome.

25687659

Vitagliano A

2015

Empiric inositol supplementation in normal-weight non insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects.

25687660

Lagan? AS

2015

Authors' reply to: Empiric inositol supplementation in normal-weight non-insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects.

25690158

Wu H

2015

Associations between TNF-? and interleukin gene polymorphisms with polycystic ovary syndrome risk: a systematic review and meta-analysis.

25690654

Cheng Y

2015

Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP.

25691449

Franz M

2015

Prospective evaluation of the learning curve of fertiloscopy with and without ovarian drilling.

25693209

Beltadze K

2015

Ovarian reserve in the women of late reproductive age after conservative treatment of polycystic ovary syndrome in adolescence.

25693210

Beltadze K

2015

Diagnostic features of polycystic ovary syndrome in adolescents (review).

25695289

Maranon R

2015

Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats.

25695720

Mereness AL

2015

Developmental programming by androgen affects the circadian timing system in female mice.

25695883

Gervais A

2015

Follicular fluid concentrations of lipids and their metabolites are associated with intraovarian gonadotropin-stimulated androgen production in women undergoing in vitro fertilization.

25695884

Jiang L

2015

MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome.

25701301

Yildiz BO

2015

Approach to the patient: contraception in women with polycystic ovary syndrome.

25702158

Tepav?evi? S

2015

Cardiac fatty acid uptake and metabolism in the rat model of polycystic ovary syndrome.

25706363

Wall DJ

2015

ACR appropriateness Criteria? infertility.

25709638

Rahiminejad ME

2014

The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndrome.

25710389

Klement AH

2015

The use of aromatase inhibitors for ovulation induction.

25710566

Palomba S

2015

Aromatase inhibitors for ovulation induction.

25711494

Huang R

2015

Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome.

25712810

Akcal? A

2015

Elevated matrix metalloproteinase-8 in saliva and serum in polycystic ovary syndrome and association with gingival inflammation.

25714674

Malin SK

2015

Pancreatic ?-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-?B activation and systemic inflammation.

25714677

Cree-Green M

2015

Peripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids.

25714787

Mousa A

2015

Vitamin D and cardiometabolic risk factors and diseases.

25714876

Gulino FA

2016

Intrafollicular nerve growth factor concentration in patients with polycystic ovary syndrome: a case-control study.

25716399

Esmaeilzadeh S

2014

Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.

25716630

Thethi TK

2015

ROLE OF INSULIN SENSITIZERS ON CARDIOVASCULAR RISK FACTORS IN POLYCYSTIC OVARIAN SYNDROME: A META-ANALYSIS.

25719299

Liang Y

2015

Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.

25721191

Valkenburg O

2015

Follicle-stimulating hormone receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (World Health Organization class 2) anovulatory subfertility.

25722221

Ghazeeri G

2015

Inadequacy of initiating rosuvastatin then metformin on biochemical profile of polycystic ovarian syndrome patients.

25722515

Hussain A

2015

Prevalence of psychiatric disorders in patients with a diagnosis of polycystic ovary syndrome in kashmir.

25723858

Muscogiuri G

2015

Focus on vitamin D and the adrenal gland.

25725679

Banu LM

2015

Correlation of hyperinsulinemia with hyperandrogenemia in primary infertile women with polycystic ovary syndrome.

25726702

Vitek W

2015

Off-label drug use in the treatment of polycystic ovary syndrome.

25731152

Wang LH

2015

4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syndrome in Chinese patients: a meta-analysis.

25736975

Madsen HN

2015

Impact of metformin on anti-M?llerian hormone in women with polycystic ovary syndrome: a secondary analysis of a randomized controlled trial.

25738264

Su C

2015

Testosterone enhances lipopolysaccharide-induced interleukin-6 and macrophage chemotactic protein-1 expression by activating the extracellular signal-regulated kinase 1/2/nuclear factor-?B signalling pathways in 3T3-L1 adipocytes.

25739031

Yildizhan R

2015

Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up.

25739338

Carlomagno G

2015

Myo-inositol: with or without.

25740067

Meczekalski B

2015

Study on the zona pellucida 4 (ZP4) gene sequence and its expression in the ovaries of patients with polycystic ovary syndrome.

25743212

Larsson I

2016

Dietary intake, resting energy expenditure, and eating behavior in women with and without polycystic ovary syndrome.

25745486

Dogan BA

2014

Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome.

25745494

Daneshian Z

2015

Antimullerian hormone and its receptor gene expression in prenatally androgenized female rats.

25750105

Piltonen TT

2015

Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro.

25756387

Pasquali R

2015

A comprehensive approach in diagnosing the polycystic ovary syndrome.

25758722

Zheng G

2015

Association of Serum Heavy Metals and Trace Element Concentrations with Reproductive Hormone Levels and Polycystic Ovary Syndrome in a Chinese Population.

25761516

L?vvik TS

2015

Pregnancy and perinatal outcomes in women with polycystic ovary syndrome and twin births: a population-based cohort study.

25763280

de Souza-J?nior JE

2015

Polycystic ovary syndrome: aggressive or protective factor for the retina? Evaluation of macular thickness and retinal nerve fiber layers using high-definition optical coherence tomography.

25763388

McRae C

2013

Metabolite Profiling in the Pursuit of Biomarkers for IVF Outcome: The Case for Metabolomics Studies.

25763405

Rojas J

2014

Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth.

25763406

Rojas J

2014

The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus.

25763591

Walczewska M

2015

[Diagnosis of benign ovarian lesions using imaging techniques].

25766251

De Fr?ne V

2015

Gonadotropin Therapy versus Laparoscopic Ovarian Drilling in Clomiphene Citrate-Resistant Polycystic Ovary Syndrome Patients: A Retrospective Cost-Effectiveness Analysis.

25772768

Caanen MR

2015

Antim?llerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.

25772812

Chandeying P

2015

Prevalence of conditions causing chronic anovulation and the proposed algorithm for anovulation evaluation.

25776288

Mayer SB

2015

Polycystic ovary syndrome and insulin: our understanding in the past, present and future.

25780518

Qu J

2015

The Higher Response of Vascular Endothelial Growth Factor and Angiotensin-II to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome.

25781065

Spritzer PM

2015

Novel strategies in the management of polycystic ovary syndrome.

25781525

Al-Zubeidi H

2015

Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome.

25781555

Sam S

2015

Adiposity and metabolic dysfunction in polycystic ovary syndrome.

25784169

Portocarrero-Sanchez C

2015

The association between follicular size at the time of spontaneous rupture and pregnancy rates in clomiphene citrate treated PCOS patients in coit cycles.

25787215

Figurov? J

2016

Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities.

25787290

Kamangar F

2015

Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children.

25789595

Szosland K

2015

Prolactin secretion in polycystic ovary syndrome (PCOS).

25790331

Paschou SA

2015

Birth weight and polycystic ovary syndrome in adult life: is there a causal link?

25791462

Kaya MG

2015

Metformin improves endothelial function and carotid intima media thickness in patients with PCOS.

25792297

Comim FV

2015

Disorders of follicle development and steroidogenesis in ovaries of androgenised foetal sheep.

25798434

Nam H

2015

Polycystic ovary syndrome woman with heterozygous androgen receptor gene mutation who gave birth to a child with androgen insensitivity syndrome.

25801724

Li L

2015

54G/C polymorphism of SREBF-1 gene is associated with polycystic ovary syndrome.

25807833

Kowalczyk R

2015

Sexuality in women with polycystic ovary syndrome.

25809118

Wang Q

2015

Meta-analysis of the correlation between IL-6 -174 G/C polymorphism and polycystic ovarian syndrome.

25810633

Mitra S

2015

Laparoscopic ovarian drilling: An alternative but not the ultimate in the management of polycystic ovary syndrome.

25813067

Konieczna A

2015

Health risk of exposure to Bisphenol A (BPA).

25813288

Zhang J

2015

Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome.

25814168

Cahill DJ

2015

Polycystic ovary syndrome (PCOS): metformin.

25815012

Uysal S

2015

Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study.

25816425

Platt AM

2015

Insulin Resistance, Metabolic Syndrome, and Polycystic Ovary Syndrome in Obese Youth.

25818182

Ongaro L

2015

Neonatal androgenization-induced early endocrine-metabolic and ovary misprogramming in the female rat.

25818277

Sun J

2015

An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials.

25818315

Russell DL

2015

ADAMTS proteases in fertility.

25818694

K?peli Akkol E

2015

Thuja occidentalis L. and its active compound, ?-thujone: Promising effects in the treatment of polycystic ovary syndrome without inducing osteoporosis.

25819417

Katyal R

2015

Commentary on Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome.

25822940

Arduc A

2015

High prevalence of Hashimoto's thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role?

25823148

Usmani A

2014

Effect of age on uterine and ovarian morphology with polycystic ovaries.

25823186

Hussain A

2014

Dyslipidaemia in woman with polycystic ovarian syndrome: a case control study in tertiary care hospital of Karachi.